Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure.
D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002908:Chronic Disease; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006352:Heart Ventricles / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology; D007548:Isosorbide Dinitrate / Q000494:pharmacology; D005082:Physical Exertion / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D011799:Quinazolines / Q000494:pharmacology; D013318:Stroke Volume / Q000187:drug effects; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use
D010879:Piperazines; D011799:Quinazolines; D014665:Vasodilator Agents; D006830:Hydralazine; C005185:trimazosin; D007548:Isosorbide Dinitrate; D011224:Prazosin